StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Amneal Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was 14.6%. For fiscal 2025 it was 13.1%, against 8.9% the year before. The highest annual figure on record is 28.0% in fiscal 2016.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202513.1%+4.1
FY2024Dec 31, 20248.9%+0.4
FY2023Dec 31, 20238.5%+12.8
FY2022Dec 31, 2022-4.3%−11.6
FY2021Dec 31, 20217.3%+2.7
FY2020Dec 31, 20204.6%+19.9
FY2019Dec 31, 2019-15.3%−14.1
FY2018Dec 31, 2018-1.2%−24.9
FY2017Dec 31, 201723.7%−4.3
FY2016Dec 31, 201628.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202616.3%+0.9
Q1 FY2026Mar 31, 202619.6%+5.2
Q4 FY2025Dec 31, 202513.8%+3.4
Q3 FY2025Sep 30, 20259.0%−3.7
Q2 FY2025Jun 30, 202515.4%+1.8
Q1 FY2025Mar 31, 202514.4%+16.1
Q4 FY2024Dec 31, 202410.4%+8.1
Q3 FY2024Sep 30, 202412.6%+0.4
Q2 FY2024Jun 30, 202413.6%+0.2
Q1 FY2024Mar 31, 2024-1.6%−7.8
Q4 FY2023Dec 31, 20232.3%−3.6
Q3 FY2023Sep 30, 202312.2%+4.1
Q2 FY2023Jun 30, 202313.4%+48.9
Q1 FY2023Mar 31, 20236.2%+1.5
Q4 FY2022Dec 31, 20225.9%+3.8
Q3 FY2022Sep 30, 20228.1%+2.7
Q2 FY2022Jun 30, 2022-35.5%−48.1
Q1 FY2022Mar 31, 20224.7%−4.6
Q4 FY2021Dec 31, 20212.1%−1.9
Q3 FY2021Sep 30, 20215.4%+4.9
Q2 FY2021Jun 30, 202112.5%+10.2
Q1 FY2021Mar 31, 20219.3%−2.3
Q4 FY2020Dec 31, 20204.0%+9.8
Q3 FY2020Sep 30, 20200.5%+30.1
Q2 FY2020Jun 30, 20202.3%+7.0
Q1 FY2020Mar 31, 202011.6%+32.7
Q4 FY2019Dec 31, 2019-5.8%−10.5
Q3 FY2019Sep 30, 2019-29.7%−45.3
Q2 FY2019Jun 30, 2019-4.7%+39.1
Q1 FY2019Mar 31, 2019-21.2%−44.2
Q4 FY2018Dec 31, 20184.7%−22.3
Q3 FY2018Sep 30, 201815.6%−15.3
Q2 FY2018Jun 30, 2018-43.8%−60.9
Q1 FY2018Mar 31, 201823.1%–
Q4 FY2017Dec 31, 201726.9%–
Q3 FY2017Sep 30, 201730.9%–
Q2 FY2017Jun 30, 201717.2%–

More Amneal Pharmaceuticals figures

See a number that looks wrong?